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Abstract
Background: Despite intense interest in the links between the microbiome and human health, little has been
written about dysbiosis among ICU patients. We characterized microbial diversity in samples from 37 children in a
pediatric ICU (PICU). Standard measures of alpha and beta diversity were calculated, and results were compared
with data from adult and pediatric reference datasets.
Results: Bacterial 16S rRNA gene sequences were analyzed from 71 total tongue swabs, 50 skin swabs, and 77 stool
samples or rectal swabs. The mean age of the PICU patients was 2.9 years (range 1–9 years), and many were
chronically ill children that had previously been hospitalized in the PICU. Relative to healthy adults and children,
alpha diversity was decreased in PICU GI and tongue but not skin samples. Measures of beta diversity indicated
differences in community membership at each body site between PICU, adult, and pediatric groups. Taxonomic
alterations in the PICU included enrichment of gut pathogens such as Enterococcus and Staphylococcus at multiple
body sites and depletion of commensals such as Faecalibacterium and Ruminococcus from GI samples. Alpha and beta
diversity were unstable over time in patients followed longitudinally. We observed the frequent presence of
“dominant” pathogens in PICU samples at relative abundance >50%. PICU samples were characterized by loss of site
specificity, with individual taxa commonly present simultaneously at three sample sites on a single individual. Some
pathogens identified by culture of tracheal aspirates were commonly observed in skin samples from the same patient.
Conclusions: We conclude that the microbiota in critically ill children differs sharply from the microbiota of healthy
children and adults. Acknowledgement of dysbiosis associated with critical illness could provide opportunities to
modulate the microbiota with precision and thereby improve patient outcomes.
Keywords: Microbiome, Microbiota, Critical illness, Pediatric critical care, Microbial diversity, Dominance, Site specificity,
Antibiotics, Nosocomial infection, Sepsis
Background
Studies of the human microbiome have generally tar-
geted healthy volunteers or individuals with chronic dis-
eases. With the exception of newborn infants, relatively
few studies have characterized the microbiota of hospital-
ized patients [1–8], particularly those that are critically ill.
This is an important knowledge gap since dysbiosis may
contribute to adverse outcomes among ICU patients and
the cost of ICU care [9]. Obvious potential causes for dis-
ruption of the ICU microbiome include antibiotics [10],
dietary changes [11], and exposure to nosocomial patho-
gens [12].
What is known about colonization patterns in ICU pa-
tients comes largely from older, culture-dependent stud-
ies. It has been demonstrated that risk of colonization by
pathogens increases over time in the ICU [13–17] and
that colonization increases the probability of developing
a subsequent infection [5, 18–22]. Generally, these older
studies were designed to confirm the presence or ab-
sence of specific pathogens (e.g., Staphylococcus aureus).
As a result, we lack a global understanding of how the
microbiota changes during critical illness. Recently, we
and others have demonstrated in critically ill adult pa-
tients that an ICU stay is associated not only with ap-
pearance of pathogens but also loss of commensal
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organisms from multiple body sites [2, 23]. However, lit-
tle has been published on this topic with regard to critic-
ally ill children.
Here, we characterized skin, oral, and fecal microbial
communities in a cohort of critically ill children. We se-
lected these body sites because bacterial populations at
these locations may impact the risk of hospital-acquired
infections, e.g., pneumonia- and catheter-related sepsis
[24–26]. In most cases, the observed temporal and
spatial dynamics of microbial colonization differed sig-
nificantly from patterns observed in healthy children
and adults, likely reflecting both underlying illness and
the corresponding treatments (e.g., antibiotic adminis-
tration). Data from this pediatric cohort appear to valid-
ate recent reports [2] that ICU-associated dysbiosis is
generally characterized by loss of diversity, loss of body
site-specificity, and presence of pathogens at high levels
of abundance.
Results
Microbial diversity among critically ill children differs
significantly from healthy adults and children
We analyzed 16S rRNA gene pyrosequencing data from
71 tongue swabs, 50 skin swabs, and 77 GI samples (37
fecal samples, 40 rectal swabs) collected from 37 pa-
tients over 39 pediatric ICU (PICU) admissions [27].
Samples with below 200 reads following clustering were
removed from downstream analysis. A single set of sam-
ples was analyzed for 23 subjects, whereas longitudinal
series of samples were analyzed for the remaining 14
subjects (detailed metadata provided in Additional files 1
and 2). The average number of sequencing reads per sam-
ple was 2980 (463–41,180 reads). The mean age of the pa-
tients was 2.9 years (range 1–9). Of these patients, 86.5%
were chronically ill and 45.9% had a PICU stay within the
prior 6 months (mean number of days 19.8 days, range 2–
64 days). Nearly all subjects received antibiotics (89.2%)
and required mechanical ventilation (94.6%).
We compared our dataset to published 16S rRNA
gene sequences obtained from the tongue dorsum, stool,
and skin (antecubital fossa) of 227 healthy adult volun-
teers in the Human Microbiome Project [28]. Because
age impacts the microbiota [29], we also sought compar-
isons of the PICU data with healthy age-matched
children. To our knowledge, however, there are no
analogous public datasets containing microbial sequen-
cing data obtained simultaneously from multiple body
sites from individual children. Therefore, we also ana-
lyzed GI, tongue, and skin samples collected from 13
children ages 1–9 (Additional file 2) admitted to our
hospital for brief observation after minor trauma (mean
age 4.6 years; average number of pyrosequencing reads
per sample 2175; range 451–4784). These patients had
not received antibiotics in the prior 6 months, and they
received a regular diet during their hospitalization and
thus were considered a valid reference group for com-
parison with PICU patients.
Alpha diversity is an ecological measure of how many
taxonomic groups are present within each sample and
whether the abundance of these groups is evenly distrib-
uted [30]. Compared to adult and pediatric samples, PICU
GI and oral samples were significantly reduced in alpha
diversity, using either the Chao1 diversity metric or the
Shannon entropy metric (non-parametric test, all p values
<0.003) (Fig. 1). PICU skin samples were significantly
lower in diversity compared to pediatric samples, but not
HMP samples (non-parametric test, all p values <0.003).
To characterize similarities and differences in the
composition of microbial communities, we calculated
two measures of beta diversity, weighted UniFrac dis-
tances and Jaccard indices (Fig. 2; see also supporting
figures in Additional file 3). Community composition at
each body location was significantly different between
PICU populations and both reference sets (Jaccard dis-
tances, PERMANOVA p < 0.001).
To further define the PICU-associated microbiota,
LEfSe [31] was used to identify taxa at a given body site
that were either enriched or depleted specifically in
PICU samples (Additional file 4) (LEfSe p values <0.05
for all taxa listed as enriched or depleted). At the
phylum level, PICU oral samples were enriched for Bac-
teroidetes, GI samples were enriched for Firmicutes, Acti-
nobacteria, and Fusobacteria, and skin samples were
enriched for Firmicutes and Bacteroidetes. At the genus
level, PICU samples were enriched for two common ICU
pathogens (Enterococcus and Staphylococcus) at all three
body sites and enriched for Pseudomonas in GI and oral
samples. Additional features of the PICU microbiome are
displayed in Additional files 4 and 5, including the sharp
enrichment of Capnocytophaga in oral and skin samples.
Importantly, PICU samples were found to be depleted of
several commensals identified in healthy adults and
children. Depleted taxa within PICU GI samples included
several anaerobes associated with gut health, e.g., Rumino-
coccus, Roseburia, and Faecalibacterium. PICU oral sam-
ples were depleted of commensals such as Rothia and
Haemophilus, and PICU skin samples were also depleted
of Haemophilus.
Phylogenetic analysis of OTUs corresponding to Pseu-
domonadaceae indicated that some of the observed
OTUs could be assigned to a contaminant in control
samples that most closely maps to either Pseudomonas
putida or Pseudomonas fluorescens. However, most of
the observed Pseudomonadaceae OTUs in patient sam-
ples mapped to a clade of Pseudomonas aeruginosa, a
well-recognized human pathogen that was also isolated
by the hospital clinical microbiology laboratory in tra-
cheal aspirates obtained from several of the study
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subjects (Additional file 2). OTUs from the genus
Capnocytophaga were most commonly from taxa previ-
ously observed in the human oral cavity: C. leadbetteri,
C. sputigena, and C. gingivalis.
ICU samples are characterized by dominant pathogens
and loss of site specificity
The presence of a “dominant” pathogen within fecal
samples has been identified as a risk factor for subse-
quent infections caused by that same organism [5, 21].
To our knowledge, our recent study of critically ill adults
was the first to quantify the number of samples in the
Human Microbiome Project with dominant taxa [28].
We defined dominance as the presence of a single taxon
with relative abundance exceeding 50%. Here, we found
that the percentage of GI and tongue samples with dom-
inant taxa was also higher among PICU samples than
adult or pediatric samples (Fig. 3a). Although healthy
adult samples did contain many dominant taxa, these
taxa were typically normal commensals such as Propi-
onibacterium (skin) and Bacteroides (gut). By contrast,
dominant taxa in the PICU were more likely to be
pathogenic, e.g., Enterococcus (GI), Staphylococcus (skin),
Porphyromonas (tongue), Pseudomonas (tongue), Capno-
cytophaga (tongue), and Stenotrophomonas (tongue). Re-
markably, the PICU population included many subjects
in whom all examined body sites simultaneously har-
bored dominant organisms (most commonly with dif-
ferent dominant taxa at each location). This pattern
was observed only rarely among healthy children and
adults (Fig. 3b).
Another well-described feature of the human micro-
biome is site specificity. It has been demonstrated
repeatedly that microbial community membership typic-
ally varies significantly between body sites [32]. In our
study of critically ill adults, we noted that pathogenic
taxa were commonly present simultaneously at multiple
body sites at relatively high abundance. Among PICU
Fig. 1 Alpha diversity comparisons of microbial communities of PICU patients, healthy adults, and healthy children. Shown are a calculated
Chao1 species richness indices for PICU, pediatric, and reference samples and b the calculated Shannon species evenness predictions for the
same groups at each site
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patients, we observed a similar phenomenon. The genus
most commonly observed simultaneously at all three
body sites in both PICU and adult datasets was Prevo-
tella, but this phenomenon was also observed in the
PICU with Staphylococcus, Stenotrophomonas, and
Porphyromonas.
To better define the loss of site specificity in the ICU,
we calculated abundance Jaccard distances between mi-
crobial communities for each pair of body locations (gut
vs. skin, gut vs. tongue, and skin vs. tongue) from all in-
dividuals with complete sets of GI, skin, and oral se-
quencing data (Fig. 3c). Accounting for sequencing
failures from one or more body sites, we identified 120
healthy adults, 33 PICU subjects, and five healthy chil-
dren with at least one complete set of contemporaneous
samples collected from three body sites on the same day.
We found that the distance between body sites was sig-
nificantly reduced in PICU patients relative to HMP
subjects for all comparisons between sites (Welch’s two-
sample t test, p values <0.05). The distances between GI
vs. tongue and GI vs. skin samples from PICU patients
were also reduced relative to healthy children, although
the distance between tongue vs. skin samples was not re-
duced significantly. Interestingly, some paired distances
of healthy children were reduced relative to HMP sub-
jects, suggesting that age contributes partly to the devel-
opment of site-specific microbial communities.
The microbiota often but not always changes radically
during PICU admission
The mean alpha diversity of samples correlated inversely
with days spent in the PICU (Shannon diversity index,
GI r2 = 0.115; skin r2 = 0.173; oral r2 = 0.122) (Fig. 4a). A
corresponding finding was an increase in the prevalence
of dominant taxa over time among the PICU samples
(GI r2 = 0.134; skin r2 = 0.093; tongue r2 = 0.056) (Fig. 4b).
In some subjects but not all, alpha diversity recovered
Fig. 2 Beta diversity comparisons of microbial communities of PICU patients, healthy adults, and healthy children. Displayed are principal
coordinate analyses (a gut; b skin; c tongue) of abundance Jaccard distances between samples from PICU patients, healthy children, and healthy
adults. Axis labels indicate the proportion of variance explained by each principal coordinate axis
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near the end of the ICU admission (see supplemental
figure in Additional file 6).
To examine the taxonomic stability of the ICU micro-
biome over time, we calculated binary Jaccard distances
for all samples collected at adjacent time points from
the same individual and same body site, as well as binary
Jaccard distances between samples collected on the same
study date from unrelated individuals (see the figure in
Additional file 7). Overall, samples from different individ-
uals taken on the same date were significantly different
from samples collected on adjacent dates from the same in-
dividuals (GI; Wilcoxon’s rank sum test; p value <2.2e−16;
oral p value <2.2e−16; skin p value = 5.845e−09). Most
samples were more similar to other samples from the same
individual than samples from other individuals, as also
shown in a similar analysis of gut microbiota in infants
[33]. However, we observed a much broader range of
values for intra-individual comparisons in the PICU than
was observed in healthy children. This is evidence that dy-
namic temporal changes exist in the microbiota of ICU pa-
tients, as major differences were observed in a subset of
samples collected at adjacent dates from the same patient.
The potential value of analyzing temporal and spatial
variation in the microbiota is illustrated by time series
analysis of patient 6 (Fig. 4c). This 2-year-old child
was admitted to the ICU with sepsis. Blood cultures on ad-
mission were positive for growth of Enterococcus, Acineto-
bacter, and Staphylococcus (latter two organisms suspected
to be skin contaminants from venipuncture). Interest-
ingly, microbiota profiling demonstrated Enterococcus
Fig. 3 Dominant pathogens and loss of site specificity in PICU samples. a Proportion of overall samples in which more than 50% of sequencing
reads are derived from a single dominant bacterial taxon. Colored stacked bars indicate the identity of the dominant taxa. Many dominant genera
in the adult and pediatric groups are known commensals, whereas many dominant taxa identified in PICU samples are pathogenic. b Proportion
of subjects with any dominant genus present on three body sites simultaneously. Many PICU subjects harbored three distinct dominant
pathogens simultaneously at the three body sites studied. c Boxplot of abundance Jaccard distances between samples collected on the same
date from PICU, pediatric, and adult subjects. Shown are distances between GI and skin samples from the same individual, GI and tongue
samples from the same individual, and skin and tongue samples from the same individual. In all comparisons except skin vs. tongue, we found
the median distance between samples to be significantly reduced in PICU patients
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at two body sites shortly after admission (relative
abundance GI 97.9%, skin 35.8%, and tongue 0%), and
three body sites 3 days later (GI 90.6%, skin 26.9%,
and tongue 0.005%). Early tongue samples were domi-
nated by Porphyromonas. Over time, after the initi-
ation of antibiotics and resolution of clinical
symptoms, the dominant populations of Enterococcus
and Porphyromonas disappeared and alpha diversity
recovered.
Associations between clinical information and
configuration of the microbiota
We sought to characterize associations between positive
microbiology culture results and microbiota profiles. Of
the 39 PICU admissions, 27 were marked by at least one
positive culture (see metadata in Additional file 2). In
contrast to the small group of blood, wound, and urine
cultures, only the group of 31 positive tracheal aspirates
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Fig. 4 Temporal changes in the site-specific microbiota of PICU patients. a Temporal changes in the median Shannon diversity index of study
subjects followed longitudinally during their PICU admission. All p values <0.05. b Temporal changes in relative abundance of most abundant
taxa in PICU patients. With time in the ICU, dominant taxa become more prevalent at each body site. All p values <0.05. c Temporal and spatial
variation of the microbiota in a single individual. Shown here are microbial profiles for a 2-year-old chronically ill child with enterococcal sepsis.
With time and antibiotics, the dysbiosis seen on admission resolves. The enterococcal populations at all three body sites nearly disappear, and
the skin and oral communities also adopt configurations more typical of healthy individuals (e.g., Staphylococcus on the skin and Streptococcus
and Neisseria in the mouth)
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the microbiota. The pathogen isolated most frequently
in TAs was P. aeruginosa; S. aureus, Serratia marcescens,
and Stenotrophomonas maltophilia were also observed
frequently. We compared microbiota profiles of patients
with positive TAs to profiles from patients without posi-
tive cultures from any body location. Interestingly, we
found that patients with TAs positive for Serratia (1.5 vs.
<1%, Wilcoxon’s rank sum test, p value = 0.01959) and
Stenotrophomonas (3.3 vs. <1%, Wilcoxon’s rank sum
test, p value = 0.03707) harbored skin swabs (collected
within 2 days of the positive culture) with significantly
higher abundance of these same organisms than patients
without positive cultures; the same relationship did not
hold for other genera, and it did not hold true for GI or
tongue samples. These correlations between tracheal
aspirate and skin colonization patterns may represent
direct inoculation of the anterior chest wall via aerosoli-
zation. Pseudomonas was extremely common on PICU
tongue swabs but was present at varying levels of abun-
dance; a relative abundance of Pseudomonas greater
than 0.5% on a tongue swab (collected within 2 days of
the positive culture) was highly associated with the pres-
ence of a TA positive for P. aeruginosa, although this as-
sociation did not reach statistical significance (25% of
positive samples vs. 0% samples negative for Pseudo-
monas; χ2 = 1.8863, df = 1, p value = 0.1696).
Discussion
In this observational analysis of the microbiota in critic-
ally ill children, we documented loss of alpha diversity
and changes in beta diversity present relative to healthy
children and adults. The children in this study demon-
strated an abundance of nosocomial pathogens across all
body sites and a reduced abundance of gut commensals
such as Faecalibacterium. Additional features of dysbio-
sis observed in our study population were loss of site
specificity and dominance by pathogenic taxa. These
findings likely reflect numerous variables including mul-
tiple antibiotic exposures, derangements in host physi-
ology, and/or the presence of nosocomial pathogens.
More research will be required to determine the clinical
relevance of these findings, e.g., the presence of a patho-
gen at multiple body sites may represent an actionable
risk factor for nosocomial infection.
Prior investigations of the ICU microbiome have gen-
erally been restricted to a single body site (commonly
the gut) and have suffered from limitations of culture-
based approaches. Still, these studies have provided a ra-
tionale for therapeutic strategies to restore missing
commensals and/or eradicate pathogens in critically ill
patients. Two general approaches have been investigated
to “manipulate” the ICU microbiome: probiotic adminis-
tration and selective decontamination of the skin, gut, or
oropharynx. Each of these strategies carries documented
risks (e.g., antibiotic resistance) and benefits (e.g., re-
duced incidence of nosocomial infections) [34–36]. Im-
portantly, these strategies have been implemented
without personalized knowledge of the microbiota in the
patients receiving these interventions. We suggest that
such strategies may benefit from an improved under-
standing of bacterial colonization patterns in the ICU.
Even with conventional antibiotic therapy, it could be
useful to profile the microbiota in real-time before, dur-
ing, and after therapy.
Conclusions
This study adds to an emerging literature describing dys-
biosis in the ICU. Multiple groups have now reported on
loss of diversity, loss of site specificity, disappearance of
commensals, and appearance of pathogens in ICU pa-
tients. In parallel, basic and translational studies have
clearly demonstrated links between the microbiota and
immune function [37], systemic inflammation [38, 39],
metabolism [40], CNS function [41, 42], and circadian
rhythm [43]. Taken together, these studies should con-
tribute to an increased awareness among clinicians that
critical illness is associated with disturbances in the
microbiota. It is reasonable to surmise that ICU dysbio-
sis impacts the risk of short- and long-term adverse
events in the ICU including undernutrition, nosocomial
infection, and neurocognitive outcomes. Thus, we are
hopeful that real-time monitoring and modulation of
microbial populations across diverse body sites can im-
prove clinical outcomes in the ICU.
Methods
Subject recruitment and participation
Thirty-seven children (ages 1–9) admitted to the
Pediatric ICU (PICU) of the Children’s Hospital of
Pittsburgh of UPMC (August 2012 to November 2013)
were enrolled by convenience sampling according to a
protocol approved by the Institutional Review Board of
The University of Pittsburgh (#11120410). Parents of all
study subjects provided written consent for participation
in the study and for publication of study results. All
PICU patients in this age range were eligible for inclusion
except patients that were not expected to receive enteral
feedings during their PICU admission due to intestinal
disorders. Parents from 115 total PICU patients were
approached for possible participation, but many refused
participation. A single set of patient samples was collected
from most participating study subjects within 3 days of
admission to the PICU (maximum 7 days after admission).
For 14 study subjects, we analyzed twice-weekly samples
from admission until discharge from PICU (or maximum
of 28 days), with a mean length of stay of 14 days. Relevant
clinical variables were recorded at the time of sample col-
lections (see Additional files 1 and 2).
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Sample collection
All samples were collected from PICU and non-PICU
study subjects by their nurses at the Children’s Hospital of
Pittsburgh (CHP) of the University of Pittsburgh Medical
Center under supervision by a single research coordinator
(M. S.) to ensure uniformity of sample collection. At all
time points, we swabbed the skin (one single pooled sam-
ple incorporating the anterior chest wall and both anterior
thighs) and tongue dorsum. We also collected fecal sam-
ples; when subjects did not provide fecal samples, we ob-
tained a rectal swab. For each body site, the BBL
CultureSwab EZ (Becton Dickinson, Franklin Lakes, NJ)
was used for sample collection. As described, the compos-
ite skin samples were collected by swabbing the anterior
chest wall and both anterior thighs. The swabs for skin
samples were moistened prior to sample collection with a
solution of 0.1% Tween 20 (Sigma Aldrich, St. Louis, MO)
and 0.15 M NaCl (Fisher Scientific, Pittsburgh, PA) as de-
scribed in [44]. Swabs were not moistened for rectal swab
and tongue swab collections.
DNA extraction
All microbial DNA was extracted from clinical samples
using the PowerSoil DNA Isolation kit (MO BIO La-
boratories, Inc., Carlsbad, CA). Fecal samples were
added directly into bead tubes and incubated at 65 °C
for 10 min followed by 95 °C for 10 min. After addition
of 60 μL of Solution C1, the bead tubes were then
shaken horizontally on a lab mixer for 10 min at max-
imum speed using a MO BIO vortex adaptor. All
remaining steps followed the manufacturer’s protocol.
For swab samples of the tongue, skin, and rectum, the
swab head was cut off directly into bead tubes contain-
ing 60 μL of Solution C1 and then incubated at 65 °C
for 10 min. Tubes were then shaken horizontally on a
lab mixer for 2 min at maximum speed using a MO BIO
vortex adaptor. All remaining steps followed the manu-
facturer’s protocol.
16S rRNA gene amplification and sequencing
Bacterial 16S rRNA gene sequences were amplified and
sequenced with Roche 454 pyrosequencing. All sequen-
cing runs included appropriate extraction controls and
sequencing (not template added) controls (Additional
file 8). Amplicons were produced utilizing 338F and
906R primers adapted for the GS FLX Titanium pyrose-
quencing platform (Roche) to target the V2-V4 region of
the 16S rRNA gene. The primers incorporated either the
A linker, key, and a 10-nucleotide barcode (forward pri-
mer) or the B linker and key (reverse primer), followed
by a sequence targeting a conserved region of the bac-
terial 16S rRNA gene. All individual PCR amplicons
were purified, quantified, and pooled in equimolar ratios,
and the library pool was gel purified prior to submission
for sequencing as described in [45] with the exception
that 30 PCR cycles were done. Sequencing was per-
formed on the Roche/454 GS FLX+ System.
Analysis of 16S rRNA gene sequences
We analyzed our data in combination with samples from
the HMP. As the amplicons (V5-V3) generated for the
HMP project were sequenced in the opposite direction
of ours, we chose a closed OTU picking strategy to gener-
ate OTUs using the QIIME pick_closed_reference_otus.py
script with the Greengenes database as a reference, result-
ing in 13,107 predicted OTUs. Taxonomic assignment of
the OTUs was done using QIIME 1.8 [46] using green
gene database 13.8 and Uclust as a classification method.
Any sample with less than 200 reads after OTU picking
was not used. OTUs with unassigned taxonomy, or OTUs
classified as Streptophytes (potential plant contamination),
were also filtered from the OTU table.
Alpha and beta diversity
Alpha and beta diversity were calculated using QIIME
with default parameters and reads rarefied to 500 se-
quencing reads. Significant differences in alpha diversity
were assessed with a non-parametric test using the com-
pare_alpha_diversity.py script in QIIME. Variations in
beta diversity were assessed with the PERMANOVA
method and algorithms in QIIME. Distance comparisons
between adjacent time points, and between samples col-
lected on the same date were done using a custom perl
script to parse the distance matrix, and a density plot
was generated using the ggplot library in R.
Identification of differentially abundant taxa within PICU
samples
LefsE [31] was used to predict biomarker taxa for each
site, comparing across PICU, pediatric, and adult (HMP)
samples. Taxa with p values below 0.05 (with correction
for multiple comparisons) and those with a mean abun-
dance of 5% in either the PICU, pediatric, or adult (HMP)
sample groups were retained.
To identify taxa depleted in the PICU dataset, two
separate pairwise comparisons were done for each site:
between PICU and HMP samples and between PICU
and pediatric samples. Significant taxa from these were
then compared in R, and the intersection of the com-
parison (taxa enriched in both the pediatric and HMP
vs. PICU) was treated as depleted in the PICU.
Additional files
Additional file 1: Summary of study population. (XLSX 14 kb)
Additional file 2: Summary of all samples collected from PICU and non-
PICU subjects in this study with relevant clinical information. (XLSX 62 kb)
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Additional file 3: Principal coordinates analysis plots of weighted
UniFrac indices for microbial communities of PICU patients, healthy
adults, and healthy children (A, GI; B, skin; C, oral). (D) Principal
coordinates analysis plots of microbial communities from all body sites of
PICU patients, healthy adults, and healthy children. (E) Principal
coordinates analysis plots of microbial communities from all body sites of
PICU patients, healthy adults, and healthy children. Here, all PICU samples
are highlighted in red regardless of body site. Note the high proportion
of centrally located PICU samples that do not fall neatly into the GI, skin,
or oral clusters. (PDF 3067 kb)
Additional file 4: Relative abundance of taxonomic groups present at
each body site. Taxa included in this display are those that were
identified at a relative abundance of greater than 5% at any body site for
any group (i.e., either reference groups or PICU). Taxa that were identified
by LefSE as biomarkers for the PICU (red), adult (black), or pediatric (blue)
groups are marked in the grid below. (PDF 415 kb)
Additional file 5: Relative abundance of taxonomic groups depleted in
PICU samples. Taxa included in this display are those that were identified
at a relative abundance of greater than 5% at any body site for any
group (i.e., either reference groups or PICU). Depleted taxa are defined as
those enriched in both the pediatric and the HMP reference groups
relative to PICU. (PDF 183 kb)
Additional file 6: Temporal changes in the Shannon diversity index
(alpha diversity) of PICU patients. All patients and samples (A, GI; B, skin;
C, oral) were included in the primary analyses of alpha diversity, but for
simplicity, only patients with three or more samples per body site are
shown here. (PDF 5 kb)
Additional file 7: Density plots of binary Jaccard distances of samples
from the same subject on adjacent sampling dates (yellow) and samples
collected on the same study day from different individuals (blue). At all
sites, the median differences (indicated by dotted lines) between
adjacent dates from the same sample were far smaller than those taken
from different subjects on the same study day. However, the overlap of
the curves indicates that some sample sets from the same subject
differed sharply despite collection on adjacent study dates. (PDF 347 kb)
Additional file 8: Relative abundance of taxonomic groups identified in
extraction controls (labeled as EC) and no template added negative
(labeled as NTC) controls. (PDF 56 kb)
Acknowledgements
The authors wish to acknowledge Tracy Pasek, RN, DNP, Clinical Nurse Specialist
at Children’s Hospital of Pittsburgh of UPMC for the logistical support.
Funding
This study was conducted without external funding.
Availability of data and materials
All sequencing data from this study have been posted to the NIH SRA
database with accession number SRP057467. Supplemental text, figures, and
tables are also provided as additional files.
Authors’ contributions
JAC and MJM conceived the study. MS and BK enrolled the patients and
collected the samples. BF and VA processed all the samples and prepared
the DNA for sequencing. MR, RBS, AF, and MJM analyzed the data. MR, JAC,
and MJM prepared the manuscript. All authors read and approved the final
manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Parents of all study subjects provided consent for publication of de-
identified data.
Ethics approval and consent to participate
This study was approved by the Institutional Review Board of The University
of Pittsburgh (#11120410). Parents of all study subjects provided consent for
participation.
Author details
1Department of Surgery, School of Medicine, University of Pittsburgh,
Pittsburgh, USA. 2Division of Pediatric General and Thoracic Surgery,
Children’s Hospital of Pittsburgh of UPMC, Pittsburgh, USA. 3Division of
Pediatric Critical Care Medicine, Children’s Hospital of Pittsburgh of UPMC,
Pittsburgh, USA. 4Department of Epidemiology, Graduate School of Public
Health, University of Pittsburgh, Pittsburgh, USA. 5Department of Critical Care
Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, USA.
6Division of Pediatric Surgery, Children’s Hospital of Pittsburgh of UPMC,
4401 Penn Avenue, 7th Floor Faculty Pavilion, Pittsburgh, PA 15244, USA.
Received: 1 September 2016 Accepted: 24 November 2016
References
1. Kitsios GD, Morowitz MJ, Dickson RP, Huffnagle GB, McVerry BJ, Morris A.
Dysbiosis in the ICU: microbiome science coming to the bedside. J Crit
Care. 2016;38:84-91.
2. McDonald D, Ackermann G, Khailova L, Baird C, Heyland D, Kozar R,
Lemieux M, Derenski K, King J, Vis-Kampen C, Knight R, Wischmeyer PE.
Extreme dysbiosis of the microbiome in critical illness. mSphere. 2016;1:
e00199–16.
3. Dickson RP, Singer BH, Newstead MW, Falkowski NR, Erb-Downward JR,
Standiford TJ, Huffnagle GB. Enrichment of the lung microbiome with gut
bacteria in sepsis and the acute respiratory distress syndrome. Nat
Microbiol. 2016;1:16113.
4. Schubert AM, Rogers MAM, Ring C, Mogle J, Petrosino JP, Young VB,
Aronoff DM, Schloss PD. Microbiome data distinguish patients with
clostridium difficile infection and non-C. difficile-associated diarrhea from
healthy controls. MBio. 2014;5:e01021–14.
5. Ubeda C, Taur Y, Jenq RR, Equinda MJ, Son T, Samstein M, Viale A, Socci ND,
van den Brink MRM, Kamboj M, Pamer EG. Vancomycin-resistant
Enterococcus domination of intestinal microbiota is enabled by antibiotic
treatment in mice and precedes bloodstream invasion in humans. J Clin
Invest. 2010;120:4332–41.
6. Zaborin A, Smith D, Garfield K, Quensen J, Shakhsheer B, Kade M, Tirrell M,
Tiedje J, Gilbert JA, Zaborina O, Alverdy JC. Membership and behavior of
ultra-low-diversity pathogen communities present in the gut of humans
during prolonged critical illness. MBio. 2014;5:e01361–14.
7. Iwai S, Fei M, Huang D, Fong S, Subramanian A, Grieco K, Lynch SV, Huang
L. Oral and airway microbiota in HIV-infected pneumonia patients. J Clin
Microbiol. 2012;50:2995–3002.
8. Shimizu K, Ogura H, Hamasaki T, Goto M, Tasaki O, Asahara T, Nomoto K,
Morotomi M, Matsushima A, Kuwagata Y, Sugimoto H. Altered gut flora are
associated with septic complications and death in critically ill patients with
systemic inflammatory response syndrome. Dig Dis Sci. 2010;56:1171–7.
9. Dominguez TE, Chalom R, Costarino AT. The impact of adverse patient
occurrences on hospital costs in the pediatric intensive care unit. Crit Care
Med. 2001;29:169–74.
10. Ubeda C, Pamer EG. Antibiotics, microbiota, and immune defense. Trends
Immunol. 2012;33:459–66.
11. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE,
Ling AV, Devlin AS, Varma Y, Fischbach MA, Biddinger SB, Dutton RJ,
Turnbaugh PJ. Diet rapidly and reproducibly alters the human gut
microbiome. Nature. 2013;505:559-63.
12. Boyce JM. Environmental contamination makes an important contribution
to hospital infection. J Hosp Infect. 2007;65(Supplement 2):50–4. Proceedings
of the Sixth International Conference of the Hospital Infection Society.
13. Venier A-G, Leroyer C, Slekovec C, Talon D, Bertrand X, Parer S, Alfandari S,
Guerin J-M, Megarbane B, Lawrence C, Clair B, Lepape A, Perraud M, Cassier
P, Trivier D, Boyer A, Dubois V, Asselineau J, Rogues A-M, Thiébaut R. Risk
factors for Pseudomonas aeruginosa acquisition in intensive care units: a
prospective multicentre study. J Hosp Infect. 2014;88:103–8.
14. Armand-Lefèvre L, Angebault C, Barbier F, Hamelet E, Defrance G, Ruppé E,
Bronchard R, Lepeule R, Lucet J-C, Mniai AE, Wolff M, Montravers P, Plésiat
P, Andremont A. Emergence of imipenem-resistant gram-negative bacilli in
intestinal flora of intensive care patients. Antimicrob Agents Chemother.
2013;57:1488–95.
15. Huskins WC, Huckabee CM, O’Grady NP, Murray P, Kopetskie H, Zimmer L,
Walker ME, Sinkowitz-Cochran RL, Jernigan JA, Samore M, Wallace D,
Rogers et al. Microbiome  (2016) 4:66 Page 9 of 10
Goldmann DA. Intervention to reduce transmission of resistant bacteria in
intensive care. N Engl J Med. 2011;364:1407–18.
16. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A,
Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae
acquisition among hospitalized adults and effect of acquisition on mortality.
Antimicrob Agents Chemother. 2008;52:1028–33.
17. Papakonstantinou I, Angelopoulos E, Baraboutis I, Perivolioti E, Parisi M,
Psaroudaki Z, Kampisiouli E, Argyropoulou A, Nanas S, Routsi C. Risk factors
for tracheobronchial acquisition of resistant Gram-negative bacterial pathogens
in mechanically ventilated ICU patients. J Chemother. 2014;27(5):283-9.
18. Niven DJ, Laupland KB, Gregson DB, Church DL. Epidemiology of
Staphylococcus aureus nasal colonization and influence on outcome in the
critically ill. J Crit Care. 2009;24:583–9.
19. Kerver AJH, Rommes JH, Mevissen-Verhage EAE, Hulstaert PF, Vos A, Verhoef
J, Wittebol P. Colonization and infection in surgical intensive care
patients—a prospective study. Intensive Care Med. 1987;13:347–51.
20. Blot S, Depuydt P, Vogelaers D, Decruyenaere J, Waele JD, Hoste E, Peleman
R, Claeys G, Verschraegen G, Colardyn F, Vandewoude K. Colonization status
and appropriate antibiotic therapy for nosocomial bacteremia caused by
antibiotic‐resistant Gram‐negative bacteria in an intensive care unit. Infect
Control Hosp Epidemiol. 2005;26:575–9.
21. Taur Y, Xavier JB, Lipuma L, Ubeda C, Goldberg J, Gobourne A, Lee YJ,
Dubin KA, Socci ND, Viale A, Perales M-A, Jenq RR, van den Brink MRM,
Pamer EG. Intestinal domination and the risk of bacteremia in patients
undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect
Dis. 2012;55:905–14.
22. Carl MA, Ndao IM, Springman AC, Manning SD, Johnson JR, Johnston BD,
Burnham C-AD, Weinstock ES, Weinstock GM, Wylie TN, Mitreva M,
Abubucker S, Zhou Y, Stevens HJ, Hall-Moore C, Julian S, Shaikh N, Warner
BB, Tarr PI. Sepsis from the gut: the enteric habitat of bacteria that cause
late-onset neonatal bloodstream infections. Clin Infect Dis. 2014;58:1211–8.
23. Yeh A, Rogers MB, Firek B, Neal MD, Zuckerbraun BS, Morowitz MJ. Dysbiosis
across multiple body sites in critically ill adult surgical patients. Shock. 2016;
46(6):649-54.
24. Bouza E, Alvarado N, Alcalá L, Pérez MJ, Rincón C, Muñoz P. A randomized
and prospective study of 3 procedures for the diagnosis of catheter-related
bloodstream infection without catheter withdrawal. Clin Infect Dis.
2007;44:820–6.
25. Heo S-M, Haase EM, Lesse AJ, Gill SR, Scannapieco FA. Genetic relationships
between respiratory pathogens isolated from dental plaque and
bronchoalveolar lavage fluid from patients in the intensive care unit
undergoing mechanical ventilation. Clin Infect Dis Off Publ Infect Dis Soc
Am. 2008;47:1562–70.
26. Mittal R, Coopersmith CM. Redefining the gut as the motor of critical illness.
Trends Mol Med. 2014;20(4):214-23.
27. Budding AE, Grasman ME, Eck A, Bogaards JA, Vandenbroucke-Grauls CMJE,
van Bodegraven AA, Savelkoul PHM. Rectal swabs for analysis of the
intestinal microbiota. PLoS One. 2014;9:e101344.
28. Consortium THMP. Structure, function and diversity of the healthy human
microbiome. Nature. 2012;486:207–14.
29. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras
M, Magris M, Hidalgo G, Baldassano RN, Anokhin AP, Heath AC, Warner B,
Reeder J, Kuczynski J, Caporaso JG, Lozupone CA, Lauber C, Clemente JC,
Knights D, Knight R, Gordon JI. Human gut microbiome viewed across age
and geography. Nature. 2012;486:222–7.
30. Jost L. Independence of alpha and beta diversities. Ecology. 2010;91:1969–74.
31. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS,
Huttenhower C. Metagenomic biomarker discovery and explanation.
Genome Biol. 2011;12:R60.
32. Lozupone CA, Stombaugh J, Gonzalez A, Ackermann G, Wendel D, Vázquez-
Baeza Y, Jansson JK, Gordon JI, Knight R. Meta-analyses of studies of the
human microbiota. Genome Res. 2013;23:1704–14.
33. Yassour M, Vatanen T, Siljander H, Hämäläinen A-M, Härkönen T, Ryhänen
SJ, Franzosa EA, Vlamakis H, Huttenhower C, Gevers D, Lander ES, Knip M,
Group on behalf of the DS, Xavier RJ. Natural history of the infant gut
microbiome and impact of antibiotic treatment on bacterial strain diversity
and stability. Sci Transl Med. 2016;8:343ra81.
34. Boyer AF, Kollef MH. Probiotics for ventilator-associated pneumonia: the
need for a large, multicenter, randomized controlled trial. Chest. 2013;143:590–2.
35. Insights into bacterial colonization of intensive care patients’ skin: the effect of
chlorhexidine daily bathing. Eur J Clin Microbiol Infect Dis. 2015;34(5):999-1004.
36. Oostdijk EN, Kesecioglu J, Schultz MJ, et al. Effects of decontamination of
the oropharynx and intestinal tract on antibiotic resistance in icus: a
randomized clinical trial. JAMA. 2014;312:1429–37.
37. Surana NK, Kasper DL. Deciphering the tête-à-tête between the microbiota
and the immune system. J Clin Invest. 2014;124:4197–203.
38. Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru
C, Blanchard C, Junt T, Nicod LP, Harris NL, Marsland BJ. Gut microbiota
metabolism of dietary fiber influences allergic airway disease and
hematopoiesis. Nat Med. 2014;20:159–66.
39. Han YW, Wang X. Mobile microbiome: oral bacteria in extra-oral infections
and inflammation. J Dent Res. 2013;92:485–91.
40. Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota
and host metabolism. Nature. 2012;489:242–9.
41. Mayer EA, Tillisch K, Gupta A. Gut/brain axis and the microbiota. J Clin
Invest. 2015;125:926–38.
42. Victor III DW, Quigley EMM. Hepatic encephalopathy involves interactions
among the microbiota, gut, brain. Clin Gastroenterol Hepatol. 2014;12:1009–11.
43. Leone V, Gibbons SM, Martinez K, Hutchison AL, Huang EY, Cham CM, Pierre
JF, Heneghan AF, Nadimpalli A, Hubert N, Zale E, Wang Y, Huang Y, Theriault B,
Dinner AR, Musch MW, Kudsk KA, Prendergast BJ, Gilbert JA, Chang EB. Effects
of diurnal variation of gut microbes and high-fat feeding on host circadian
clock function and metabolism. Cell Host Microbe. 2015;17:681–9.
44. Fierer N, Hamady M, Lauber CL, Knight R. The influence of sex, handedness,
and washing on the diversity of hand surface bacteria. Proc Natl Acad Sci U
S A. 2008;105:17994–9.
45. Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. Bacterial
community variation in human body habitats across space and time.
Science. 2009;326:1694–7.
46. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello
EK, Fierer N, Peña AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights
D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M,
Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T,
Zaneveld J, Knight R. QIIME allows analysis of high-throughput community
sequencing data. Nat Methods. 2010;7:335–6.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Rogers et al. Microbiome  (2016) 4:66 Page 10 of 10
